INTRAOSSEOUS LINE INSERTION
480 Practical Procedures
COMPLICATIONS
1 Immediate (early)
(i) Arterial dissection, laceration or false aneurysm:
(a) less likely with subclavian route than IJV or femoral route
(b) but haemorrhage from the femoral or carotid much easier to
control than from the subclavian artery.
(ii) Route-specific injury:
(a) pneumothorax, haemothorax and cardiac arrhythmia (SCV,
IJV)
(b) malposition of subclavian vein catheter, which may ascend
into the IJV or cross the midline horizontally.
(iii) Air embolism.
(iv) Loss of guidewire.
2 Delayed (late)
(i) Local infection – more common with femoral access than with
SCV and IJV.
(ii) Systemic infection – bacteremia, endocarditis. More common
with femoral than IJV and SCV.
(iii) Venous thrombosis – incidence up to 10–25% for femoral
catheter left in situ >24 h.
(iv) Cardiac tamponade and hydrothorax.
INTRAOSSEOUS LINE INSERTION
INDICATIONS
1 Alternative access in emergent or resuscitative situation, when peripheral i.v.
access fails or will ta ke over 60 s in child.
2 Immediate venous access for administering drugs, f luids or blood products,
particularly in child aged 0–7 years, including neonates.
3 Access in adults when i.v. insertion is impossible, or delayed.
CONTRAINDICATIONS
1 Open fracture, local skin infection or osteomyelitis at proposed insertion
site.
2 Femoral fracture on ipsilateral side.
TECHNIQUE
1 Infiltrate the skin surface and periosteum with 1 mL of 1% lignocaine
(lidocaine) using a 25-gauge needle if time permits (not necessary in coma).